Dr. Ing. h.c. F. Porsche AG
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, rest of Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as provides related services. It also offers leasing, dealer and customer financing, insurance brokerage, mobility, and other finance-related services. The company was form… Read more
Dr. Ing. h.c. F. Porsche AG (DRPRF) - Total Liabilities
Latest total liabilities as of September 2025: $30.90 Billion USD
Based on the latest financial reports, Dr. Ing. h.c. F. Porsche AG (DRPRF) has total liabilities worth $30.90 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dr. Ing. h.c. F. Porsche AG - Total Liabilities Trend (2006–2024)
This chart illustrates how Dr. Ing. h.c. F. Porsche AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dr. Ing. h.c. F. Porsche AG Competitors by Total Liabilities
The table below lists competitors of Dr. Ing. h.c. F. Porsche AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acushnet Holdings Corp
NYSE:GOLF
|
USA | $1.50 Billion |
|
Atco Ltd
PINK:ACLLF
|
USA | $18.25 Billion |
|
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
|
India | ₹188.07 Billion |
|
Ansell Limited
PINK:ANSLF
|
USA | $1.34 Billion |
|
Sichuan Biokin Pharmaceutical Co. Ltd. A
SHG:688506
|
China | CN¥4.39 Billion |
|
Mankind Pharma Ltd
NSE:MANKIND
|
India | ₹132.85 Billion |
|
Metaplanet Inc.
PINK:MTPLF
|
USA | $17.84 Billion |
|
Biocon Limited
NSE:BIOCON
|
India | ₹295.40 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Dr. Ing. h.c. F. Porsche AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dr. Ing. h.c. F. Porsche AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dr. Ing. h.c. F. Porsche AG (2006–2024)
The table below shows the annual total liabilities of Dr. Ing. h.c. F. Porsche AG from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $30.47 Billion | +333.32% |
| 2023-12-31 | $7.03 Billion | -4.57% |
| 2022-12-31 | $7.37 Billion | +2093.15% |
| 2021-12-31 | $336.00 Million | +10.53% |
| 2020-12-31 | $304.00 Million | -1.30% |
| 2019-12-31 | $308.00 Million | +5.48% |
| 2018-12-31 | $292.00 Million | +2.46% |
| 2017-12-31 | $285.00 Million | -39.49% |
| 2016-12-31 | $471.00 Million | -8.37% |
| 2015-12-31 | $514.00 Million | -47.12% |
| 2014-12-31 | $972.00 Million | +19.26% |
| 2013-12-31 | $815.00 Million | -23.19% |
| 2012-12-31 | $1.06 Billion | -90.63% |
| 2011-12-31 | $11.32 Billion | -9.09% |
| 2010-12-31 | $12.45 Billion | -92.46% |
| 2009-12-31 | $165.09 Billion | +474.59% |
| 2008-12-31 | $28.73 Billion | +107.43% |
| 2007-12-31 | $13.85 Billion | +48.90% |
| 2006-12-31 | $9.30 Billion | -- |